In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention
- PMID: 10850432
In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention
Abstract
Previous research suggested that the beta-lyase-mediated production of a monomethylated selenium metabolite from Se-methylselenocysteine is a key step in cancer chemoprevention by this agent. In an attempt to affirm the concept, the present study was designed to evaluate the activity of methylseleninic acid, a compound that represents a simplified version of Se-methylselenocysteine without the amino acid moiety, thereby obviating the need for beta-lyase action. The in vitro experiments showed that methylseleninic acid was more potent than Se-methylselenocysteine in inhibiting cell accumulation and inducing apoptosis in TM12 (wild-type p53) and TM2H (nonfunctional p53) mouse mammary hyperplastic epithelial cells, and these effects were not attributable to DNA damage, as determined by the comet assay. In general, methylseleninic acid produced a more robust response at one-tenth the concentration of Se-methylselenocysteine. It is possible that these cell lines may have only a modest ability to generate a monomethylated selenium species from Se-methylselenocysteine via the beta-lyase enzyme. In contrast, methylseleninic acid already serves as a preformed active monomethylated metabolite, and this could be an underlying reason why methylseleninic acid acts more rapidly and exerts a more powerful effect than Se-methylselenocysteine in vitro. Interestingly, the distinction between these two compounds disappeared in vivo, where their cancer chemopreventive efficacies were found to be very similar to each other [in both methylnitrosourea and dimethylbenz(a)anthracene rat mammary tumor models]. The beta-lyase enzyme is present in many tissues; thus, animals have an ample capacity to metabolize Se-methylselenocysteine systemically. Therefore, Se-methylselenocysteine would be expected to behave like methylseleninic acid if beta-lyase is no longer a limiting factor. Taken together, the present in vitro and in vivo results provide strong evidence in support of our earlier hypothesis that a monomethylated selenium metabolite is important for cancer chemoprevention. Methylseleninic acid could be an excellent tool, especially for molecular mechanism studies in cell culture, and some of these attributes are discussed.
Similar articles
-
Chemical form of selenium, critical metabolites, and cancer prevention.Cancer Res. 1991 Jan 15;51(2):595-600. Cancer Res. 1991. PMID: 1824684
-
Chemoprevention with triphenylselenonium chloride in selenium-deficient rats.Anticancer Res. 2000 Nov-Dec;20(6B):4179-82. Anticancer Res. 2000. PMID: 11205245
-
Cancer chemoprevention: selenium as a prooxidant, not an antioxidant.Med Hypotheses. 2006;67(2):318-22. doi: 10.1016/j.mehy.2006.01.058. Epub 2006 Mar 30. Med Hypotheses. 2006. PMID: 16574336
-
Mechanisms of mammary cancer chemoprevention by organoselenium compounds.Mutat Res. 2004 Jul 13;551(1-2):181-97. doi: 10.1016/j.mrfmmm.2004.02.023. Mutat Res. 2004. PMID: 15225592 Review.
-
Chemical forms of selenium for cancer prevention.J Trace Elem Med Biol. 2005;19(2-3):141-50. doi: 10.1016/j.jtemb.2005.09.003. Epub 2005 Oct 24. J Trace Elem Med Biol. 2005. PMID: 16325529 Review.
Cited by
-
Toxicology and pharmacology of synthetic organoselenium compounds: an update.Arch Toxicol. 2021 Apr;95(4):1179-1226. doi: 10.1007/s00204-021-03003-5. Epub 2021 Apr 1. Arch Toxicol. 2021. PMID: 33792762 Free PMC article. Review.
-
Current Knowledge on the Importance of Selenium in Food for Living Organisms: A Review.Molecules. 2016 May 10;21(5):609. doi: 10.3390/molecules21050609. Molecules. 2016. PMID: 27171069 Free PMC article. Review.
-
Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer.Int J Cancer. 2013 Nov;133(9):2225-33. doi: 10.1002/ijc.28202. Epub 2013 May 9. Int J Cancer. 2013. PMID: 23575870 Free PMC article.
-
Redox-active selenium compounds--from toxicity and cell death to cancer treatment.Nutrients. 2015 May 13;7(5):3536-56. doi: 10.3390/nu7053536. Nutrients. 2015. PMID: 25984742 Free PMC article. Review.
-
Arsenic-induced inflammation in workers.Mol Biol Rep. 2019 Apr;46(2):2371-2378. doi: 10.1007/s11033-019-04694-x. Epub 2019 Feb 19. Mol Biol Rep. 2019. PMID: 30783936
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous